Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP362996.RA5ikwmf7Rpoi0nVzqhzi77BM1fdl4f6ew4LEQT21Jtbs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP362996.RA5ikwmf7Rpoi0nVzqhzi77BM1fdl4f6ew4LEQT21Jtbs130_assertion type Assertion NP362996.RA5ikwmf7Rpoi0nVzqhzi77BM1fdl4f6ew4LEQT21Jtbs130_head.
- NP362996.RA5ikwmf7Rpoi0nVzqhzi77BM1fdl4f6ew4LEQT21Jtbs130_assertion description "[After 3 months of therapy, levels of left ventricular end diastolic diameter, NT-proBNP, CRP, Th1, Th1/Th2, IFN-?, T-bet mRNA and T-bet/GATA-3 mRNA decreased in the two CCI subgroups, but levels in the CCI intervention group were lower in comparison to the control group.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP362996.RA5ikwmf7Rpoi0nVzqhzi77BM1fdl4f6ew4LEQT21Jtbs130_provenance.
- NP362996.RA5ikwmf7Rpoi0nVzqhzi77BM1fdl4f6ew4LEQT21Jtbs130_assertion evidence source_evidence_literature NP362996.RA5ikwmf7Rpoi0nVzqhzi77BM1fdl4f6ew4LEQT21Jtbs130_provenance.
- NP362996.RA5ikwmf7Rpoi0nVzqhzi77BM1fdl4f6ew4LEQT21Jtbs130_assertion SIO_000772 23413906 NP362996.RA5ikwmf7Rpoi0nVzqhzi77BM1fdl4f6ew4LEQT21Jtbs130_provenance.
- NP362996.RA5ikwmf7Rpoi0nVzqhzi77BM1fdl4f6ew4LEQT21Jtbs130_assertion wasDerivedFrom befree-20140225 NP362996.RA5ikwmf7Rpoi0nVzqhzi77BM1fdl4f6ew4LEQT21Jtbs130_provenance.
- NP362996.RA5ikwmf7Rpoi0nVzqhzi77BM1fdl4f6ew4LEQT21Jtbs130_assertion wasGeneratedBy ECO_0000203 NP362996.RA5ikwmf7Rpoi0nVzqhzi77BM1fdl4f6ew4LEQT21Jtbs130_provenance.